CEO and CFO Depart Liberty Health Sciences

Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Liberty Health Sciences Announces Executive and Board Changes

TORONTO, Feb. 22, 2019 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”), as mentioned in the Company’s Feb 12, 2019 press release, continues to work towards enhancing its directors and senior executives based in the United States, to more closely align with the US geographical focus of the business.

In accordance with this strategy, George Scorsis, the Company’s Chief Executive Officer, has resigned and will also be stepping down from his Board position. In the interim, Mr. Scorsis will be replaced by Victor E. Mancebo, the Company’s current President who is a resident in the State of Florida and has in-depth knowledge of the Company’s day to day operations. Victor’s appointment ensures that there will be no need for a ramping up period to become familiar with the Company’s operations. Victor will serve as the Company’s interim Chief Executive Officer and will be appointed to fill the vacancy on the Board until a replacement is sourced for the role.

Similarly, the Company is announcing the resignation of Rene Gulliver, the Company’s Chief Financial Officer effective April 14, 2019. Mr. Gulliver will be replaced by Scott Meyers, currently the Company’s Director of Finance, who shall serve in the role of interim Chief Financial Officer. Mr. Meyers was born and raised in the Illinois area.

The Company has commenced an executive recruitment effort to recruit US individuals to fill the permanent Chief Executive Officer and Chief Financial Officer roles.

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.

Original press release

For fact-based information on Liberty Health Sciences, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter